A new study published in Lancet Public Health believes Flint’s RX Kids program may be helping improve outcomes for newborns ...

A comprehensive fall prevention program integrated into primary healthcare systems significantly reduced falls among older adults, according to a large cluster randomized clinical trial published in ...

Following formation of the committee, each student must submit a program of study to the Office of the Registrar for approval. The Program of Study form details the minimum coursework and credits that ...

Please provide your email address to receive an email when new articles are posted on . Diabetes Prevention Program investigators learned March 10 that government funding had been terminated. They ...

Cancer survivors who practiced yoga reported improvements in mood, anxiety and fatigue compared to standard care alone, a clinical trial found.

PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: ...

Federal and state financial aid regulations allow courses which are required to complete a student’s program of study to be included when determining financial aid eligibility. Courses which are not ...

AMES, IA – A new study from Iowa State University found men convicted of domestic violence were charged with significantly fewer violent and nonviolent charges one year after completing a treatment ...

Sacramento State Geography major Gail Dulay knew she needed to polish her people skills to be successful in urban planning. So, she jumped at the chance to work on a public outreach project with the ...

The authors’ multidisciplinary care management program shows promise, as the reduction in per-patient per-month spending was $116. However, these financial benefits took time to materialize.

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials National estimates of cancer ...

May 29 () - Agios Pharmaceuticals said on Friday it ‌will stop developing its experimental ‌drug for a form of blood ​cancer after a mid-stage trial failed to show enough benefit. The ⁠company said ...